Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Quizartinib Indicated for the Treatment of FLT3-ITD AML

Quizartinib is indicated for the treatment of acute myeloid leukaemia, an aggressive cancer of the blood and bone marrow. Image courtesy of Cancer Research UK.

  • Quizartinib
  • Quizartinib
  • Quizartinib

Go Top